Improved Efficacy of Oral Immunotherapy Using Non-Digestible Oligosaccharides in a Murine Cow’s Milk Allergy Model: A Potential Role for Foxp3+ Regulatory T Cells
BackgroundOral immunotherapy (OIT) is a promising therapeutic approach to treat food allergic patients. However, there are some concerns regarding its safety and long-term efficacy. The use of non-digestible oligosaccharides might improve OIT efficacy since they are known to directly modulate intest...
Main Authors: | Marlotte M. Vonk, Mara A. P. Diks, Laura Wagenaar, Joost J. Smit, Raymond H. H. Pieters, Johan Garssen, Betty C. A. M. van Esch, Léon M. J. Knippels |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fimmu.2017.01230/full |
Similar Items
-
The efficacy of oral and subcutaneous antigen-specific immunotherapy in murine cow’s milk- and peanut allergy models
by: Marlotte M. Vonk, et al.
Published: (2017-09-01) -
Non-digestible oligosaccharides scFOS/lcFOS facilitate safe subcutaneous immunotherapy for peanut allergy
by: Laura Wagenaar, et al.
Published: (2019-04-01) -
Butyrate Enhances Desensitization Induced by Oral Immunotherapy in Cow’s Milk Allergic Mice
by: Marlotte M. Vonk, et al.
Published: (2019-01-01) -
A network-based approach for identifying suitable biomarkers for oral immunotherapy of food allergy
by: Jolanda H. M. van Bilsen, et al.
Published: (2019-04-01) -
Dietary Intervention with β-Lactoglobulin-Derived Peptides and a Specific Mixture of Fructo-Oligosaccharides and Bifidobacterium breve M-16V Facilitates the Prevention of Whey-Induced Allergy in Mice by Supporting a Tolerance-Prone Immune Environment
by: Atanaska I. Kostadinova, et al.
Published: (2017-10-01)